SCHEMBL720482

SCHEMBL720482

CCOc1ccc(Nc2nc(Cl)ccc2[N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
POLB P06746 2/20 0.51
MAPT P10636 8/20 0.50
ALDH1A1 P00352 2/20 0.50
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NFKB1 P19838 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPK1 P28482 2/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
FGFR4 P22455 2/20 0.46
RPS6KB2 Q9UBS0 1/20 0.46
LMNA P02545 1/20 0.46
AURKA O14965 1/20 0.46
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL720311 0.86 MERTK (0.61) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL16014941 0.84 PIN1 (0.67) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL2195898 0.83 MAPT (0.51) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL29393268 0.82 MAPT (0.69) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL21672383 0.82 MAPT (0.69) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL718271 0.81 MAPT (0.51) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL22719050 0.81 MAPT (0.54) NPC1MEN1KMT2APOLBMAPT
SCHEMBL29535826 0.81 MAPT (0.54) NPC1MEN1KMT2APOLBMAPT
SCHEMBL27782705 0.81 NPC1 (0.54) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL22719062 0.80 MAOA (0.51) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933106-B2 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2015-01-13 US disclosed
EP-2351739-B1 2-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS THE INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PRAPARATION METHODS AND USES THEREOF INST PHARM & TOXICOLOGY AMMS (CN) 2013-07-31 EP disclosed
US-20120053213-A1 2-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PREPARATION METHODS AND USES THEREOF INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2012-03-01 US disclosed
EP-2351739-A1 THE 2-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS THE INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PRAPARATION METHODS AND USES THEREOF Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China (CN) 2011-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053213-A1 2-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PREPARATION METHODS AND USES THEREOF PNP, DPYD, TYMP NPC1 1678/4885RAB9A 3726/4885MEN1 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.